Repeated oral trazodone in male and female rats: Sex-dependent anxiolytic-like effects, altered male sexual motivation and dose-related testicular and epididymal changes in the same animals.

IF 2.4 3区 心理学 Q1 BEHAVIORAL SCIENCES
Thais de Oliveira Navarro, Lilian Marques de Sá, Milena Rodrigues Soares, Leonardo Calisse, Maria Martha Bernardi, André Rinaldi Fukushima, Helenice de Souza Spinosa
{"title":"Repeated oral trazodone in male and female rats: Sex-dependent anxiolytic-like effects, altered male sexual motivation and dose-related testicular and epididymal changes in the same animals.","authors":"Thais de Oliveira Navarro, Lilian Marques de Sá, Milena Rodrigues Soares, Leonardo Calisse, Maria Martha Bernardi, André Rinaldi Fukushima, Helenice de Souza Spinosa","doi":"10.1016/j.pbb.2026.174292","DOIUrl":null,"url":null,"abstract":"<p><p>Trazodone is a multimodal antidepressant and hypnotic used off-label for insomnia and anxiety in humans and, in veterinary medicine, as an anxiolytic and sedative in dogs and cats. In both settings it is given repeatedly, largely to individuals who are not depressed, and with little regard to sex. Its behavioural and reproductive consequences have been examined separately, in separate animals; here both were assessed in the same cohort. Male and female Wistar rats received trazodone hydrochloride at 5, 10 or 20 mg/kg/day (T5, T10, T20) or vehicle by gavage for 28 consecutive days (postnatal days 60-87; n = 6-8/group), with behavioural testing from postnatal day 88, approximately 24 h after the final dose. Open-field locomotion was unaltered in either sex; female rearing was reduced only at 20 mg/kg. In the elevated plus-maze, trazodone increased open-arm time and reduced closed-arm time in males (T5, T10) and in females (T10, T20), the effective dose range being lower in males. In an incentive-zone test, T20 males spent more time in the male-incentive zone while time near the female, approaches and latency were unchanged - a loss of directional preference rather than increased sexual interest. In the same males, blinded histomorphometry showed reduced seminiferous epithelium thickness at every dose and reduced caput epididymal luminal area and perimeter; testicular and epididymal severity scores were increased at 10 and 20 mg/kg, while gonadosomatic index, relative liver weight and hepatic scores were unchanged. The dose that altered male sexual incentive behaviour was also the dose with the most pronounced testicular change. The mechanism was not tested here and remains to be established.</p>","PeriodicalId":19893,"journal":{"name":"Pharmacology Biochemistry and Behavior","volume":" ","pages":"174292"},"PeriodicalIF":2.4000,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Biochemistry and Behavior","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1016/j.pbb.2026.174292","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Trazodone is a multimodal antidepressant and hypnotic used off-label for insomnia and anxiety in humans and, in veterinary medicine, as an anxiolytic and sedative in dogs and cats. In both settings it is given repeatedly, largely to individuals who are not depressed, and with little regard to sex. Its behavioural and reproductive consequences have been examined separately, in separate animals; here both were assessed in the same cohort. Male and female Wistar rats received trazodone hydrochloride at 5, 10 or 20 mg/kg/day (T5, T10, T20) or vehicle by gavage for 28 consecutive days (postnatal days 60-87; n = 6-8/group), with behavioural testing from postnatal day 88, approximately 24 h after the final dose. Open-field locomotion was unaltered in either sex; female rearing was reduced only at 20 mg/kg. In the elevated plus-maze, trazodone increased open-arm time and reduced closed-arm time in males (T5, T10) and in females (T10, T20), the effective dose range being lower in males. In an incentive-zone test, T20 males spent more time in the male-incentive zone while time near the female, approaches and latency were unchanged - a loss of directional preference rather than increased sexual interest. In the same males, blinded histomorphometry showed reduced seminiferous epithelium thickness at every dose and reduced caput epididymal luminal area and perimeter; testicular and epididymal severity scores were increased at 10 and 20 mg/kg, while gonadosomatic index, relative liver weight and hepatic scores were unchanged. The dose that altered male sexual incentive behaviour was also the dose with the most pronounced testicular change. The mechanism was not tested here and remains to be established.

在雄性和雌性大鼠中反复口服曲唑酮:性别依赖性焦虑样效应,雄性性动机改变以及剂量相关的睾丸和附睾变化。
曲唑酮是一种多模式抗抑郁药和催眠药,在标签外用于治疗人类失眠和焦虑,在兽医中用作狗和猫的抗焦虑药和镇静剂。在这两种情况下,它都被反复给予,主要是给那些没有抑郁的人,很少涉及到性。它的行为和生殖后果已在不同的动物中分别进行了检查;在这里,两者都在同一队列中进行评估。雄性和雌性Wistar大鼠分别以5、10或20 mg/kg/天(T5、T10、T20)或载药方式灌胃盐酸曲唑酮,连续28天(出生后60-87天; = 6-8/组),从出生后第88天开始,即最终剂量后约24 小时进行行为测试。两种性别的野外运动没有改变;雌鼠饲养量仅在20 mg/kg时减少。在升高的加迷宫中,曲唑酮增加了男性(T5、T10)和女性(T10、T20)的开臂时间,减少了闭臂时间,男性的有效剂量范围较低。在激励区测试中,T20雄性在男性激励区待的时间更长,而在雌性附近待的时间更长,方法和潜伏期没有变化——方向性偏好的丧失,而不是性兴趣的增加。在同一雄性中,盲法组织形态学测量显示,每次给药时精系上皮厚度减少,头附睾管腔面积和周长减少;在10和20 mg/kg时,睾丸和附睾严重程度评分升高,而性腺指数、相对肝脏重量和肝脏评分不变。改变男性性激励行为的剂量也是睾丸变化最明显的剂量。这一机制没有在这里得到检验,有待建立。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
2.80%
发文量
122
审稿时长
38 days
期刊介绍: Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书